SORAFENAT

SORAFENAT

Product Details:

X

Product Description

Sorafenat - Sorafenib

 

Sorafenat contains sorafenib, which is a small molecular inhibitor of several tyrosine protein kinases.

Manufactured By:

Natco Pharma Ltd.

Indication:

Sorafenat is used for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer.

Available As:
200 mg tablets.
Bottle of 120 Tablets

Note:

Sorafenat is a prescription drug and should be used under proper medical guidance and advice.





Back to top